The Future of Tumor Testing | American Lung Association

This website uses cookies. By continuing you are agreeing to our privacy policy.

Tumor Testing and the Transformation of Lung Cancer Treatment: The Future of Tumor Testing

Progress is being made every day in the fight against lung cancer and incorporating tumor testing and precision medicine into a person's treatment plan creates a more targeted or customized approach to treating lung cancer. The American Lung Association convened a panel of experts to share the latest developments in this exciting area of lung cancer treatment.

Moderated by our National Director of Lung Cancer Education, Carly Ornstein, MPH CHES, our panel included Justin F. Gainor, M.D, Center for Thoracic Cancers, Massachusetts General Hospital Cancer Center, and Assistant Professor of Medicine, Harvard Medical School; and Sherri Millis M.S., Ph.D., Senior Manager, Clinical Collaborations Foundation Medicine Inc.

Generously supported by AstraZeneca, Bristol-Myers Squibb, Foundation Medicine, Pfizer, and Merck & Co., Inc.

For more information, visit Lung.org/tumor-testing.

Transcript


    Page Last Updated: November 9, 2018

    Sign up for updates

    Stay up to date on the latest news and information on the fight against lung cancer.

    Red button with telephone
    Ask An Expert

    Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

    Get help
    Red button of two hand prints
    We need your generous support

    Make a difference by delivering research, education and advocacy to those impacted by lung disease.

    Button of turquoise LUNG FORCE swirl
    What is LUNG FORCE?

    LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

    Get involved
    Join the fight for healthy lungs and healthy air.
    Donate Now.